First Time Loading...

Concord Medical Services Holdings Ltd
NYSE:CCM

Watchlist Manager
Concord Medical Services Holdings Ltd Logo
Concord Medical Services Holdings Ltd
NYSE:CCM
Watchlist
Price: 0.6322 USD 9% Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

CCM Price Targets Summary
Concord Medical Services Holdings Ltd

Wall Street analysts forecast CCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CCM is 1.2 USD .

CCM Lowest Forecast
Wall Street Target
Not Available
CCM Average Forecast
Wall Street Target
1.2 USD
90% Upside
CCM Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
1.2 USD
90% Upside
Highest
Price Target
Not Available
Concord Medical Services Holdings Ltd Competitors:
Price Targets
A
AND
Andlauer Healthcare Group Inc
24% Upside
A
9860
Adicon Holdings Ltd
72% Upside
HIMS
Hims & Hers Health Inc
34% Upside
DNTL
dentalcorp Holdings Ltd
64% Upside
A
AND
Andlauer Healthcare Group Inc
24% Upside
A
9860
Adicon Holdings Ltd
72% Upside
HIMS
Hims & Hers Health Inc
34% Upside
DNTL
dentalcorp Holdings Ltd
64% Upside
E
1846
Euroeyes International Eye Clinic Ltd
100% Upside
RDNT
RadNet Inc
4% Upside
DVA
DaVita Inc
2% Downside
ADUS
Addus Homecare Corp
6% Upside

Revenue
Forecast

Revenue Estimate
Concord Medical Services Holdings Ltd

For the last 8 years the compound annual growth rate for Concord Medical Services Holdings Ltd's revenue is -3%. The projected CAGR for the next 3 years is -62%.

-3%
Past Growth
-62%
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Concord Medical Services Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Concord Medical Services Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
CCM intrinsic value, competitors valuation, and company profile.
DCF Valuation
CCM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CCM stock valuation using valuation multiples.
Wall Street Estimates
CCM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CCM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CCM's stock price target?
Price Target
1.2 USD

According to Wall Street analysts, the average 1-year price target for CCM is 1.2 USD .

What is Concord Medical Services Holdings Ltd's Revenue forecast?
Projected CAGR
-62%

For the last 8 years the compound annual growth rate for Concord Medical Services Holdings Ltd's revenue is -3%. The projected CAGR for the next 3 years is -62%.

ALPHA SPREAD
Join more than 135,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.